Aberrant micrornas expression patterns in pancreatic cancer and their clinical translation

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 5, 2013, Pages 361-369

  Du, Yiqi ^a   Liu, Minghao ^a   Gao, Jun ^a   Li, Zhaoshen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

biomarker; early diagnosis; gene regulation; microRNA; oncogene; pancreatic cancer

Indexed keywords

ALPHA TROPOMYOSIN; ANTAGOMIR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EXPORTIN 5; FK 506 BINDING PROTEIN; FLUOROURACIL; GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; MICRORNA 196A; MICRORNA 21; MICRORNA 21 INHIBITOR; MICRORNA 210; MICRORNA 221; MICRORNA 222; MICRORNA 34A; MICRORNA 375; PUMA PROTEIN; STAT1 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; APOPTOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; EARLY DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; INSULINOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MICROARRAY ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS ISLET CELL TUMOR; PANCREAS METASTASIS; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; RNA SYNTHESIS; RNA TRANSLATION; TRANSLATION REGULATION; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; UPREGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878826126     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1389     Document Type: Review

References (115)

1. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program[J]. Oncologist 2007;12:20.
2. Sergeant G, Vankelecom H, Gremeaux L, et al. Role of cancer stem cells in pancreatic ductal adenocarcinoma[J]. Nat Rev Clin Oncol 2009;6:580.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell 1993;75:843.
4. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function[J]. Cell 2004;116:281.
5. Ambros V. The functions of animal microRNAs[J]. Nature 2004;431:350.
6. Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA[J]. Nature 2000;408:86.
7. Li M, Marin-Muller C, Bharadwaj U, et al. MicroRNAs: Control and loss of control in human physiology and disease[ J]. World J Surg 2009;33:667.
8. Nelson KM, Weiss GJ. MicroRNAs and cancer: Past, present, and potential future[J]. Mol Cancer Ther 2008;7:3655.
9. Singh PK, Brand RE, Mehla K. MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol 2012; 9:334.
10. Cho WC. MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273.
11. Cho WC. MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010;1805:209.
12. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II[J]. EMBO J 2004;23:4051.
13. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs[J]. RNA 2004;10:1957.
14. Lin SL, Miller JD, Ying SY. Intronic microRNA (miRNA)[J]. J Biomed Biotechnol 2006;2006:26818.
15. Zeng Y. Principles of micro-RNA production and maturation[ J]. Oncogene 2006;25:6156.
16. Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: Stepwise processing and subcellular localization[J]. EMBO J 2002;21:4663.
17. Gregory RI, Yan KP, Amuthan G, et al. The Microprocessor complex mediates the genesis of microRNAs[J]. Nature 2004;432:235.
18. Denli AM, Tops BB, Plasterk RH, et al. Processing of primary microRNAs by the Microprocessor complex[J]. Nature 2004;432:231.
19. Yi R, Qin Y, Macara IG, et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs[J]. Genes Dev 2003;17:3011.
20. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors[J]. Science 2004;303:95.
21. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs[J]. RNA 2004;10:185.
22. Gregory RI, Chendrimada TP, Cooch N, et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing[J]. Cell 2005;123:631.
23. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing[J]. Nature 2005;436:740.
24. Hammond SM, Bernstein E, Beach D, et al. An RNAdirected nuclease mediates post-transcriptional gene silencing in Drosophila cells[J]. Nature 2000;404:293.
25. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias[J]. Cell 2003;115:209.
26. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation[J]. Nat Rev Genet 2004;5:522.
27. Mohammed Abba HA. MicroRNAs as regulatory molecules in cancer a focus on models defining miRNA functions[ J]. Cancer Models 2009;6:13.
28. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation ofmRNA[J]. Proc Natl Acad Sci U S A 2006;103:4034.
29. Dong J, Zhao YP, Zhou L, et al. Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells[J]. Arch Med Res 2011;42:8.
30. Allawi HT, Dahlberg JE, Olson S, et al. Quantitation of microRNAs using a modified Invader assay[J]. RNA 2004; 10:1153.
31. Wang J, Yi X, Tang H, et al. Direct quantification of microRNA at low picomolar level in sera of glioma patients using a competitive hybridization followed by amplified voltammetric detection. Anal Chem 2012;84:6400.
32. Xia QS, Ishigaki Y, Sun L, et al. [Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells]. Zhonghua Yi Xue Za Zhi 2010;90: 123. Chinese.
33. Sun Y, Gregory KJ, Chen NG, et al. Rapid and direct microRNA quantification by an enzymatic luminescence assay. Anal Biochem 2012;429:11.
34. Baker MB, Bao G, Searles CD. In vitro quantification of specific microRNA using molecular beacons. Nucleic Acids Res 2012;40:e13.
35. Zhang J, Li Z, Wang H, et al. Ultrasensitive quantification of mature microRNAs by real-time PCR based on ligation of a ribonucleotide-modified DNA probe. Chem Commun (Camb) 2011;47:9465.
36. Sun M, Estrov Z, Ji Y, et al. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells[J]. Mol Cancer Ther 2008;7:464.
37. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method[J]. Nat Protoc 2008;3:1101.
38. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic isletspecific microRNA regulates insulin secretion[J]. Nature 2004;432:226.
39. Jiang J, Lee EJ, Gusev Y, et al. Real-time expression profiling of microRNA precursors in human cancer cell lines[J]. Nucleic Acids Res 2005;33:5394.
40. Ohuchida K, Mizumoto K, Lin C, et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 Gene[J]. Ann Surg Oncol 2012;19:2394.
41. Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer[J]. Int J Cancer 2007;120:1046.
42. Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior[J]. J Clin Oncol 2006;24:4677.
43. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[ J]. Proc Natl Acad Sci U S A 2006;103:2257.
44. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and nonneoplastic processes in pancreatic ductal adenocarcinoma[J]. Oncogene 2007;26:4442.
45. Panarelli NC, Chen YT, Zhou XK, et al. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma[J]. Pancreas 2012;41:685.
46. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis[J]. JAMA 2007;297:1901.
47. Dillhoff M, Liu J, Frankel W, et al. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival[J]. J Gastrointest Surg 2008;12:2171.
48. Yu J, Ohuchida K, Mizumoto K, et al. MicroRNA, hsa-miR- 200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation[J]. Mol Cancer 2010;9:169.
49. Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by realtime PCR analysis[J]. World J Surg 2009;33:698.
50. Kong X, Du Y, Wang G, et al. Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis[J]. Dig Dis Sci2011;56:602.
51. Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease[J]. Cancer Prev Res (Phila) 2009;2:807.
52. Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells[J]. Int J Cancer 2008;123:372.
53. Bhaumik D, Scott GK, Schokrpur S, et al. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells[J]. Oncogene 2008;27:5643.
54. Hurst DR, Edmonds MD, Scott GK, et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis[J]. Cancer Res 2009; 69:1279.
55. Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR- 155 is a biomarker of early pancreatic neoplasia[J]. Cancer Biol Ther 2009;8:340.
56. Wang B, Hsu SH, Majumder S, et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3[J]. Oncogene 2010;29:1787.
57. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma[J]. Clin Cancer Res 2008;14:2690.
58. Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy[J]. Clin Cancer Res 2009;15:5060.
59. Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma[J]. Biochem Biophys Res Commun 2005;334:1351.
60. He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma[J]. Proc Natl Acad Sci U S A 2005;102:19075.
61. Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia[J]. N Engl J Med 2005; 353:1793.
62. Yanaihara N, Caplen N, Bowman E, et al. Unique micro- RNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell 2006;9:189.
63. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis[J]. Mol Cell 2007;26:745.
64. Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells[J]. PLoS One 2009;4:e6816.
65. Yu S, Lu Z, Liu C, et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer[ J]. Cancer Res 2010;70:6015.
66. Olie RA, Hafner C, Kuttel R, et al. Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages[J]. J Invest Dermatol 2002; 118:505.
67. Croce CM. Causes and consequences of microRNA dysregulation in cancer[J]. Nat Rev Genet 2009;10:704.
68. Park JK, Lee EJ, Esau C, et al. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma[ J]. Pancreas 2009;38:e190.
69. Moriyama T, Ohuchida K, Mizumoto K, et al. MicroRNA- 21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance[ J]. Mol Cancer Ther 2009;8:1067.
70. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells[J]. EMBO Rep 2008;9:582.
71. Wang F, Xue X, Wei J, et al. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations[J]. Br J Cancer 2010;103:567.
72. Yan H, Wu J, Liu W, et al. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells[J]. Hum Gene Ther 2010;21:1723.
73. Li Y, Vandenboom TN, Wang Z, et al. miR-146a suppresses invasion of pancreatic cancer cells[J]. Cancer Res 2010; 70:1486.
74. Lin F, Wang X, Jie Z, et al. Inhibitory effects of miR-146b-5p on cell migration and invasion of pancreatic cancer by targeting MMP16[J]. J Huazhong Univ Sci Technolog Med Sci 2011;31:509.
75. Laurila EM, Sandstrom S, Rantanen LM, et al. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells[J]. Genes Chromosomes Cancer 2012;51:557.
76. Giovannetti E, Funel N, Peters GJ, et al. MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity[J]. Cancer Res 2010;70:4528.
77. Hwang JH, Voortman J, Giovannetti E, et al. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer[J]. PLoS One 2010;5:e10630.
78. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network[J]. Nature 2007;447:1130.
79. Zenz T, Mohr J, Eldering E, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia[J]. Blood 2009;113:3801.
80. Ali S, Ahmad A, Banerjee S, et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF[J]. Cancer Res 2010;70:3606.
81. Soubani O, Ali AS, Logna F, et al. Re-expression of miR- 200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis 2012; 33:1563.
82. Holly EA, Chaliha I, Bracci PM, et al. Signs and symptoms of pancreatic cancer: A population-based case-control study in the San Francisco Bay area[J]. Clin Gastroenterol Hepatol 2004;2:510.
83. Xu Q, Zhang TP, Zhao YP. Advances in early diagnosis and therapy of pancreatic cancer[J]. Hepatobiliary Pancreat Dis Int 2011;10:128.
84. Sahani DV, Shah ZK, Catalano OA, et al. Radiology of pancreatic adenocarcinoma: Current status of imaging[J]. J Gastroenterol Hepatol 2008;23:23.
85. Volmar KE, Vollmer RT, Jowell PS, et al. Pancreatic FNA in 1000 cases: A comparison of imaging modalities[J]. Gastrointest Endosc 2005;61:854.
86. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol 2008;141:672.
87. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature 2005;435:834.
88. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Cancer Res 2005;65:7065.
89. Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias[J]. Proc Natl Acad Sci U S A 2004; 101:11755.
90. Michael MZ, O' Connor SM, van Holst PN, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia[ J]. Mol Cancer Res 2003;1:882.
91. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues[J]. Clin Chem 2008;54:1716.
92. Bauer AS, Keller A, Costello E, et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012;7:e34151.
93. Ansari D, Chen BC, Dong L, et al. Pancreatic cancer: translational research aspects and clinical implications. World J Gastroenterol 2012;18:1417.
94. Piepoli A, Tavano F, Copetti M, et al. Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One 2012;7:e33663.
95. Jiao LR, Frampton AE, Jacob J, et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One 2012;7: e32068.
96. Cordelier P, Torrisani J. MicroRNAs in Pancreatic Cancer: Potential Interests as Biomarkers and Therapeutic Tools. In: Cho WC (ed.), MicroRNAs in Cancer Translational Research, New York: Springer, 2011;287.
97. Frampton AE, Krell J, Jacob J, et al. microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Expert Rev Anticancer Ther 2011;11:1837.
98. Albulescu R, Neagu M, Albulescu L, et al. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn 2011; 11:101.
99. Greither T, Grochola LF, Udelnow A, et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival[J]. Int J Cancer 2010;126:73.
100. Hanoun N, Delpu Y, Suriawinata A, et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis[J]. Clin Chem 2010;56:1107.
101. Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia[J]. Semin Oncol 2007; 34:303.
102. Gold DV, Modrak DE, Ying Z, et al. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis[ J]. J Clin Oncol 2006;24:252.
103. Liu J, Gao J, Du Y, et al. Combination of plasma micro- RNAs with serum CA19-9 for early detection of pancreatic cancer[J]. Int J Cancer 2012;131:683.
104. Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer[J]. Clin Chem 2012;58:610.
105. Ho AS, Huang X, Cao H, et al. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer[J]. Transl Oncol 2010;3:109.
106. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature 1998;391:806.
107. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature 2001;411:494.
108. Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J]. J Hepatol 2012; 56:1371.
109. Morrissey DV, Lockridge JA, Shaw L, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs[J]. Nat Biotechnol 2005;23:1002.
110. Fedorov Y, Anderson EM, Birmingham A, et al. Off-target effects by siRNA can induce toxic phenotype[J]. RNA 2006;12:1188.
111. Tsuda N, Ishiyama S, Li Y, et al. Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells[J]. Clin Cancer Res 2006;12:6557.
112. Tsuda N, Mine T, Ioannides CG, et al. Synthetic microRNA targeting glioma-associated antigen-1 protein[J]. Methods Mol Biol 2009;487:435.
113. Ma Y, Yu S, Zhao W, et al. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2[J]. Cancer Lett 2010;298:150.
114. Paterson EL, Kolesnikoff N, Gregory PA, et al. The micro- RNA-200 family regulates epithelial to mesenchymal transition[ J]. Sci World J 2008;8:901.
115. Torrisani J, Bournet B, du Rieu MC, et al. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression[J]. Hum Gene Ther 2009;20:831.